Suppr超能文献

韩国病态肥胖患者的腹腔镜远端胃癌切除术。

Laparoscopic distal gastrectomy for gastric cancer in morbidly obese patients in South Korea.

机构信息

Division of Gastroenterologic Surgery, Department of Surgery, Chonnam National University Hwasun Hospital, Hwasun, Korea.

出版信息

J Gastric Cancer. 2014 Sep;14(3):187-95. doi: 10.5230/jgc.2014.14.3.187. Epub 2014 Sep 30.

Abstract

PURPOSE

Laparoscopic gastrectomy in obese patients has been investigated in several studies, but its feasibility has rarely been examined in morbidly obese patients, such as in those with a body mass index (BMI) of ≥30 kg/m(2). The present study aimed to evaluate the technical feasibility and safety of laparoscopic gastrectomy in morbidly obese patients with gastric cancer.

MATERIALS AND METHODS

A total of 1,512 gastric cancer patients who underwent laparoscopic distal gastrectomy (LDG) were divided into three groups: normal (BMI<25 kg/m(2), n=996), obese (BMI 25~30 kg/m(2), n=471), and morbidly obese (BMI≥30 kg/m(2), n=45). Short-term surgical outcomes, including the course of hospitalization and postoperative complications, were compared between the three groups.

RESULTS

The morbidly obese group had a significantly longer operating time (240 minutes vs. 204 minutes, P=0.010) than the normal group, but no significant differences were found between the groups with respect to intraoperative blood loss or other complications. In the morbidly obese group, the postoperative morbidity and mortality rates were 13.3% and 0%, respectively, and the mean length of hospital stay was 8.2 days, which were not significantly different from those in the normal group. Subgroup analysis showed that postoperative complication rates were not high in morbidly obese patients, independent of the type of anastomosis technique used and level of lymph node dissection.

CONCLUSIONS

LDG is technically feasible and safe in morbidly obese patients with a BMI of ≥30 kg/m(2) and early gastric carcinoma. Except for a longer operating time, LDG might represent a reasonable treatment option in these patients.

摘要

目的

腹腔镜胃切除术已在多项研究中进行了探讨,但是其在病态肥胖患者(如 BMI≥30kg/m2 的患者)中的可行性很少被研究。本研究旨在评估腹腔镜胃切除术治疗病态肥胖胃癌患者的技术可行性和安全性。

材料和方法

共有 1512 例接受腹腔镜远端胃切除术(LDG)的胃癌患者分为三组:正常组(BMI<25kg/m2,n=996)、肥胖组(BMI 25~30kg/m2,n=471)和病态肥胖组(BMI≥30kg/m2,n=45)。比较三组患者的短期手术结果,包括住院时间和术后并发症。

结果

病态肥胖组的手术时间明显长于正常组(240 分钟比 204 分钟,P=0.010),但两组术中出血量或其他并发症无显著差异。病态肥胖组的术后发病率和死亡率分别为 13.3%和 0%,平均住院时间为 8.2 天,与正常组无显著差异。亚组分析显示,无论吻合技术类型和淋巴结清扫程度如何,病态肥胖患者的术后并发症发生率均不高。

结论

BMI≥30kg/m2 的早期胃癌病态肥胖患者行 LDG 具有技术可行性和安全性。除了手术时间较长外,LDG 可能是这些患者的合理治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a06c/4199886/8618a59c205e/jgc-14-187-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验